Last reviewed · How we verify
NCT05053945
Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
trial testing Esophagogastroduodenoscopy in Helicobacter Pylori in 260 participants. Currently enrolling.
1 December 2025
Quick facts
| Lead sponsor | Chinese University of Hong Kong |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 260 |
| Start date | 15 May 2020 |
| Primary completion | 1 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 2 locations across Hong Kong |
Drugs / interventions tested
- Esophagogastroduodenoscopy
Conditions studied
- Helicobacter Pylori — all drugs for Helicobacter Pylori →
- Atrophic Gastritis — all drugs for Atrophic Gastritis →
- Intestinal Metaplasia — all drugs for Intestinal Metaplasia →
Sponsor
Chinese University of Hong Kong
Who can join
18 and older, any sex, with Helicobacter Pylori or Atrophic Gastritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Since much is unknown about factors that lead to progression of the pre-neoplastic lesions and cancer. In addition, there is ongoing debate on the optimal surveillance intervals and techniques. To solve these important clinical questions, the establishment of a registry for a longitudinal study is planned.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05053945
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Esophagogastroduodenoscopy
Trials testing the same drug.
- NCT06557733 — An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis · Phase 2 · recruiting
- NCT07152756 — Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores · not yet recruiting
- NCT07156591 — Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention · not yet recruiting
- NCT06408220 — Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer · NA · recruiting
- NCT06269380 — Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy · NA · completed
Other recruiting trials for Helicobacter Pylori
Currently open trials in the same condition.
- NCT07232095 — 7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy · Phase 4 · recruiting
- NCT07253948 — Distribution Characteristics of Helicobacter Pylori · recruiting
- NCT06943781 — Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection · recruiting
- NCT06871579 — Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori · NA · recruiting
- NCT07122024 — Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment · Phase 4 · recruiting
Other Chinese University of Hong Kong trials
Trials by the same sponsor.
- NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
- NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
- NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
- NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
- NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05053945 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
- Last refreshed: 29 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05053945.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing